Oral Drug Development
Oral Dosage Development
Our range of oral dose delivery options gives your drug excellent solubility and stability, delivering the right dosage at the right time in the patient’s body. This is where Pii’s proven and experienced formulation scientists will be invaluable in the early stages of development to ensure meeting the target product profile (TPP) by providing a forward-thinking approach to anticipate and eliminate potential future challenges.
Our Core Offerings:
Highly Potent Compounds (including Safebridge Category IV and Hormones)
DEA Controlled Substances (Schedule I-V, L1)
Combination of Multiple APIs
Pre-formulation to Phase III Studies
Bioavailability enhancement
Modified-and controlled-release tablets, capsules, and suspensions
Formulation of complex drug products
Multi-particulate tablets and capsules
Spray drying dispersions (SDD)
Particle engineering (e.g. nanoparticles, drug layering, coated particles)
Solubility enhancement (e.g. SMEDDS, lipid-based systems, SDD, nanoparticles)
Zero-order controlled-release tablets (e.g. laser drilling)
